mRNA |
VX-11e |
GDSC1000 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
EX-527 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |